Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Accounts Payables of $74.7 million for Q4 2025, down 5.57% year-on-year from $79.1 million in Q4 2024, and down 5.57% on a QoQ basis from $79.1 million in Q4 2024.

Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Accounts Payables for 7 consecutive years, with $74.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Accounts Payables fell 5.57% year-over-year to $74.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $74.7 million (down 5.57% YoY) and the FY2025 annual result came in at $74.7 million, down 5.57% from the prior year.
  • Accounts Payables fell to $74.7 million in Q4 2025 per CURLF's latest filing, from $79.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for CURLF reached as high as $101.9 million in Q2 2024 and fell as low as $38.7 million in Q1 2021.
  • A 5-year average of $70.9 million and a median of $72.3 million in 2022 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2021 — Accounts Payables surged 97.31% — and 2025, when it retreated 5.57%.
  • Year by year, Accounts Payables stood at $60.8 million in 2021, then surged by 32.96% to $80.8 million in 2022, then dropped by 1.82% to $79.3 million in 2023, then declined by 0.24% to $79.1 million in 2024, then dropped by 5.57% to $74.7 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods registered $74.7 million, $79.1 million, and $89.8 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 507.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 1.67 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 74.73 Mn
Dec 31, 2024 79.13 Mn
Sep 30, 2024 89.75 Mn
Jun 30, 2024 101.89 Mn
Dec 31, 2023 79.32 Mn
Sep 30, 2023 63.72 Mn
Jun 30, 2023 69.36 Mn
Dec 31, 2022 80.79 Mn
Mar 31, 2022 69.88 Mn
Sep 30, 2021 60.76 Mn
Jun 30, 2021 42.96 Mn
Mar 31, 2021 38.65 Mn
Dec 31, 2020 47.04 Mn
Sep 30, 2020 30.80 Mn
Dec 31, 2019 12.74 Mn